Ultime notizie per Danimer Scientific (OTC:DNMR) Azioni

Danimer Scientific

Danimer Scientific Inc creates more sustainable, more natural ways to make plastic products sold under the proprietary Nodax brand name. The company's renewable and sustainable biopolymers have helped create plastic products that are biodegradable and compostable. Danimer Scientific's products return to nature instead of polluting lands and waters. Its technology can be found in a vast array of plastic end-use products that people use every day. Applications for its biopolymers include additives, aqueous coatings, fibers, filaments, films, and injection-molded articles, among others. Geographically, the company generates a majority of its revenue from the United States and the rest from Germany, Poland, Belgium, and other regions.

Danimer Scientific Inc Ordinary Shares - Class A

Danimer Scientific Inc

DANIMER SCIENTIFIC INC A by Danimer Scientific, Inc.

Brazil Potash Corp. ("Brazil Potash" or the "Company") (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/GRO#NYSE">GRO</a>), a mineral development company with a critical mineral potash mining project, today announced that it has entered into a definitive agreement establishing an equity line of credit ("ELOC") with Alumni Capital LP ("Alumni"), an institutional investor. Brazil Potash anticipates that this agreement will provide the company with a flexible source of funding, enabling the Company to progress its flagship Autazes Potash Project.
As Brazil Potash works towards key milestones, it anticipates the ELOC will enable judicious planning for the timing and amount of any equity sales, which will be critical as it advances site preparation and construction activities for the fully-permitted Autazes Project.
Under the terms of the agreement, Brazil Potash has the right to sell, and Alumni has the obligation to purchase, up to $75 million worth of common shares over a 24-month period at prices that are based on the market price at the time of each sale to Alumni, subject to the satisfaction of certain customary conditions. Brazil Potash, at its sole discretion, controls the timing and amount of all sales of common shares associated with the ELOC, subject to the limitations contained in the SPA.
 &nbsp;

News

Brazil Potash Agrees On Establishing Equity Line Of Credit With Alumni Capital To Progress Flagship Autazes Potash Project

HC Wainwright &amp; Co. analyst Heiko Ihle maintains Solaris Resources (AMEX:<a class="ticker" href="https://www.benzinga.com/stock/SLSR#AMEX">SLSR</a>) with a Buy and raises the price target from $10 to $11.

Price Target

Analyst Ratings

SLSR

HC Wainwright & Co. Maintains Buy on Solaris Resources, Raises Price Target to $11

Earnings

Earnings Beats

SOPH

Sophia Genetics Q1 EPS $(0.26), Inline, Sales $17.78M Beat $16.93M Estimate

Jacobs Solutions (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/J#NYSE">J</a>) reported quarterly earnings of $1.43 per share which beat the analyst consensus estimate of $1.39 by 2.88 percent. This is a 25.13 percent decrease over earnings of $1.91 per share from the same period last year. The company reported quarterly sales of $2.91 billion which beat the analyst consensus estimate of $2.18 billion by 33.48 percent. This is a 31.83 percent decrease over sales of $4.27 billion the same period last year.

Jacobs Solutions Q2 Adj. EPS $1.43 Beats $1.39 Estimate, Sales $2.91B Beat $2.18B Estimate

Telsey Advisory Group analyst Dana Telsey maintains a.k.a. Brands Holding (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/AKA#NYSE">AKA</a>) with a Market Perform and lowers the price target from $18 to $9.

Telsey Advisory Group Maintains Market Perform on a.k.a. Brands Holding, Lowers Price Target to $9

Marathon Petroleum (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/MPC#NYSE">MPC</a>) reported quarterly losses of $(0.24) per share which beat the analyst consensus estimate of $(0.53) by 54.72 percent. This is a 108.63 percent decrease over earnings of $2.78 per share from the same period last year. The company reported quarterly sales of $31.85 billion which beat the analyst consensus estimate of $29.58 billion by 7.66 percent. This is a 4.10 percent decrease over sales of $33.21 billion the same period last year.

Marathon Petroleum Q1 EPS $(0.24) Beats $(0.53) Estimate, Sales $31.85B Beat $29.58B Estimate

Constellation Energy (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/CEG#NASDAQ">CEG</a>) affirms FY2025 Adj EPS guidance from $8.90-$9.60 to $8.90-$9.60 vs $9.51 analyst estimate..

Guidance

Constellation Energy Affirms FY2025 Adj EPS Guidance of $8.90-$9.60 vs $9.51 Est

Needham analyst Mike Matson reiterates Artivion (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/AORT#NYSE">AORT</a>) with a Buy and maintains $32 price target.

Reiteration

AORT

Needham Reiterates Buy on Artivion, Maintains $32 Price Target

Constellation Energy (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/CEG#NASDAQ">CEG</a>) reported quarterly earnings of $2.14 per share which missed the analyst consensus estimate of $2.18 by 1.83 percent. This is a 17.58 percent increase over earnings of $1.82 per share from the same period last year. The company reported quarterly sales of $6.79 billion which beat the analyst consensus estimate of $5.44 billion by 24.78 percent. This is a 10.18 percent increase over sales of $6.16 billion the same period last year.

Earnings Misses

Constellation Energy Q1 Adj. EPS $2.14 Misses $2.18 Estimate, Sales $6.79B Beat $5.44B Estimate

General

AMST

Amesite Launches Higher-Priced Enterprise Tier Of Service Of Flagship App NurseMagic

Jefferies analyst Omar Nokta maintains Matson (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/MATX#NYSE">MATX</a>) with a Buy and maintains $125 price target.

MATX

Jefferies Maintains Buy on Matson, Maintains $125 Price Target

MPLX (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/MPLX#NYSE">MPLX</a>) reported quarterly earnings of $1.10 per share which missed the analyst consensus estimate of $1.12 by 1.79 percent. This is a 12.24 percent increase over earnings of $0.98 per share from the same period last year. The company reported quarterly sales of $3.12 billion which missed the analyst consensus estimate of $3.14 billion by 0.52 percent. This is a 9.77 percent increase over sales of $2.85 billion the same period last year.

MPLX

MPLX Q1 EPS $1.10 Misses $1.12 Estimate, Sales $3.12B Miss $3.14B Estimate

SRFM

Surf Air Mobility Subsidiary Mokulele Airlines Launches New Interline Agreement With Japan Airlines

Chardan Capital analyst Daniil Gataulin maintains uniQure (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/QURE#NASDAQ">QURE</a>) with a Buy and maintains $38 price target.

QURE

Chardan Capital Maintains Buy on uniQure, Maintains $38 Price Target

Chatham Lodging (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/CLDT#NYSE">CLDT</a>) is looking for Q2 FFO of $0.32-$0.36 vs $0.36 analyst estimate. sees sales of $79.000 million-$80.200 million vs $82.30 million analyst estimate.

CLDT

Chatham Lodging Sees Q2 AFFO $0.32-$0.36 vs $0.36 Est; Sees Sales $79.000M-$80.200M vs $82.30M Est

Duke Energy (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/DUK#NYSE">DUK</a>) affirms FY2025 Adj EPS guidance from $6.17-$6.42 to $6.17-$6.42 vs $6.32 analyst estimate..

Duke Energy Affirms FY2025 Adj EPS Guidance of $6.17-$6.42 vs $6.32 Est

Chatham Lodging (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/CLDT#NYSE">CLDT</a>) lowers FY2025 FFO guidance from $1.01-$1.11 to $0.95-$1.03 vs $1.05 analyst estimate. Lowers FY2025 sales outlook from $298.00 million-$305.00 million to $295.00 million-$298.00 million vs $306.35 million estimate.

Chatham Lodging Lowers FY2025 AFFO Guidance From $1.01-$1.11 to $0.95-$1.03 Vs $1.05 Est; Lowers Sales Guidance From $298.00M-$305.00M To $295.00M-$298.00M Vs $306.35M Est

Duke Energy Q1 Adj. EPS $1.76 Beats $1.60 Estimate, Total Operating Revenues $8.25B Beat $8.06B Estimate

Babcock &amp; Wilcox Enterprises, Inc. ("B&amp;W" or the "Company") (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/BW#NYSE">BW</a>) announced it has sold the majority of the assets of its Denmark-based Babcock &amp; Wilcox A/S (B&amp;W A/S) subsidiary to Kanadevia Inova Denmark A/S (Kanadevia Inova) for $20 million, a portion of which will be used for the deployment of B&amp;W's BrightLoop&#x2122; hydrogen production and carbon capture facility in Massillon, Ohio. Kanadevia Inova is a global greentech leader, pioneering innovative solutions for the energy transition and circular economy.

Babcock & Wilcox Sells Majority Of Its Denmark-Based Subsidiary Assets To Kanadevia Inova For $20M

Tesla Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/TSLA#NASDAQ">TSLA</a>) reportedly has over 10,000 units of the Cybertruck in its domestic inventory as the company grapples with poor sales and an aging line-up of vehicles.
What Happened: Elon Musk's EV giant could be sitting on over $800 million worth of Cybertruck inventory, according <a href="https://electrek.co/2025/05/05/tesla-cybertruck-inventory-skyrockets-to-record-high/">to</a> an Electrek report on Monday.
The report suggests that despite there not being a way to track Tesla units in the U.S., listings of Tesla models can be tracked. The report also outlines how Tesla may publish a single listing for multiple vehicles at the same location with the same features, which could indicate the company has more inventory.
Tesla did not immediately respond to<a href="http://pro.benzinga.com"> Benzinga's</a> request for comment.
Why It Matters: Tesla has been grappling with declining sales figures in the U.S. as well as Europe. The company's market share in Europe currently stands at 2%, down from 2.9% last year, and it registered 571 units sold in Spain, according to experts.
Cybertruck also went through a <a href="https://www.benzinga.com/news/25/04/44967503/cybertruck-gets-a-down-to-earth-redesign-as-tesla-shifts-to-traditional-pickup-marketing-amid-poor-s">shift in marketing strategy</a>, which positions the vehicle as a capable, rugged pickup truck and expands on its utilitarian quotient. The company also released a <a href="https://www.benzinga.com/markets/equities/25/04/44755221/tesla-unveils-new-cybertruck-long-range-trim-with-a-362-mile-range-and-reduced-features">cheaper, RWD variant </a>of the Cybertruck to appeal to a wider customer base.
Tesla's new <a href="https://www.benzinga.com/tech/25/04/44857987/tesla-experiences-151-decline-in-new-vehicle-registrations-in-california-report">vehicle registrations </a>also fell in California, and the company's profits declined by over 71% YoY. This comes at a time when the company was reportedly exploring <a href="https://www.benzinga.com/25/04/45124373/tesla-board-explored-replacing-elon-musk-as-tesla-ceo-a-month-ago-report">a future without Musk</a>, which both the billionaire as well as the company have categorically denied.
Price Action: TSLA currently trades for $280.26 on the NASDAQ, according to<a href="https://pro.benzinga.com/dashboard"> Benzinga Pro data</a>.
Check out more of Benzinga's Future Of Mobility coverage by<a href="https://www.benzinga.com/topic/mobility"> following this link.</a>
Read Next:
<ul>
<li><a href="https://www.benzinga.com/markets/equities/25/05/45214525/gary-black-flags-47-projected-drop-in-teslas-april-europe-sales-predicts-6-decline-in-2025-deliveries">Gary Black Flags 47% Projected Drop In Tesla&#8217;s April Europe Sales, Predicts 6% Decline In 2025 Deliveries</a></li>
</ul>
Photo courtesy: Shutterstock

Comments

Danimer Scientific

Notizie

Ultime notizie per Danimer Scientific (OTC:DNMR) Azioni

Notizie

PARTNER/COLLABORATORE

BENZINGA NEL MONDO